Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
12/15/2010 | CN101912608A Method for producing paratyphus living vaccine for piglets |
12/15/2010 | CN101912603A Compound of prostate stem cell antigen and heat shock protein and preparation method and application thereof |
12/15/2010 | CN101912601A Stabilised solid compositions of factor VII polypeptides |
12/15/2010 | CN101912600A Method for improving stability of insulin in solution |
12/15/2010 | CN101912491A Pills for treating cardiovascular diseases and preparation method |
12/15/2010 | CN101912462A External paste for treating burn and scald and preparation method thereof |
12/15/2010 | CN101912447A Rhizoma corydalis total alkaloids self-emulsifying drug delivery system and preparation method and application thereof |
12/15/2010 | CN101912412A Zeolites for delivery of nitric oxide |
12/15/2010 | CN101912405A Medicinal composition for treating cattle endometritis |
12/15/2010 | CN101912403A Cefoperazone sodium and tazobactam sodium medicinal composition microsphere injection |
12/15/2010 | CN101912397A Flupentixol composition |
12/15/2010 | CN101912395A Medical composite containing pirfenidone and preparation method thereof |
12/15/2010 | CN101912393A Solid preparation of clopidogrel or medicinal salts of clopidogrel and preparation method thereof |
12/15/2010 | CN101912392A Pharmaceutical compositions comprising colloidal silicon dioxide |
12/15/2010 | CN101912376A Matrine vaginal effervescent tablets with bilayer structure and preparation method |
12/15/2010 | CN101912375A Metformin controlled release tablet |
12/15/2010 | CN101912374A Quetiapine sustained release tablet and preparation method thereof |
12/15/2010 | CN101912373A Stable cefeclor dispersible tablet and preparation method thereof |
12/15/2010 | CN101912372A Nilvadipine liposome tablets |
12/15/2010 | CN101912369A Method for preparing bendamustine hydrochloride freeze-dried preparation |
12/15/2010 | CN101912367A Depot formulations of iloperidone and a star polymer |
12/15/2010 | CN101912366A Degradable gel microspheres interposed in bronchus and application thereof |
12/15/2010 | CN101912364A Ginkgolide B liposome medicinal composition |
12/15/2010 | CN101912363A Dissolving ultrafiltration-spray drying-molecule dispersion coating-hydration palletizing-freeze drying method for preparing liposome combination medicine |
12/15/2010 | CN101912362A Fat emulsion pre-emulsifying concentrated solution for teniposide intravenous injection and preparation method thereof |
12/15/2010 | CN101912361A Cefotiam hydrochloride/anhydrous sodium carbonate medicinal composition suspension injection and new use thereof |
12/15/2010 | CN101912360A Ibuprofen suspension and preparation method thereof |
12/15/2010 | CN101912359A 恩诺沙星注射液 Enrofloxacin Injection |
12/15/2010 | CN101912358A Washing-free hand disinfectant and preparation method |
12/15/2010 | CN101912357A Gel paste preparation and preparation method thereof |
12/15/2010 | CN101912356A Aztreonam/arginine medicinal composition lipid microsphere injection |
12/15/2010 | CN101632634B N(2)-L-alanyl-L-glutamine liposome injection and preparation method thereof |
12/15/2010 | CN101623264B Cefmetazole sodium proliposome preparation |
12/15/2010 | CN101461783B Netilmicin sulphate nano micelle preparation for intravenous injection and preparation method thereof |
12/15/2010 | CN101332178B Medicinal preparation for oral darifenacin or medicine salt thereof |
12/15/2010 | CN101327296B Compound Chinese medicine preparation for treating and improving insomnia and preparation method thereof |
12/15/2010 | CN101283987B Chloroquine liposomes freeze-dried powder injection and preparation method thereof |
12/15/2010 | CN101249170B Preparation of houttuynia cordata freeze-dried powder needle for injections |
12/15/2010 | CN101234163B , preparation method of Chinese medicine composition for treating kidney deficiency and stasis resistance syndrome |
12/15/2010 | CN101176722B Scutellaria glycosides freeze dried injection solution and preparation method thereof |
12/15/2010 | CN101138635B Fibrin glue vasodilation agent sustained-release long-acting composition |
12/15/2010 | CN101125147B Glucosamine calcium medicine preparation, preparation method and application thereof |
12/15/2010 | CN101123989B A process for the preparation of a piroxicam: betacyclodextrin inclusion compound |
12/15/2010 | CN101031321B Perorally administrable antimicrobial composition |
12/14/2010 | USRE41996 Composition and methods for enhancing receptor-mediated cellular internalization |
12/14/2010 | US7851618 Aminated complex-type sugar chain derivatives and process for the production thereof |
12/14/2010 | US7851586 Peptides for activation and inhibition of δPKC |
12/14/2010 | US7851511 Emulsifier for highly liquid W/O emulsion based on partly crosslinked polyglycerol esters of polyhydroxystearic acid |
12/14/2010 | US7851506 orally administering sodium oxybate a dosage form, to a patient, suffering from apnea, sleep time disturbances, narcolepsy, cataplexy, sleep paralysis, hypnagogic hallucination, sleep arousal, insomnia, and nocturnal myoclonus |
12/14/2010 | US7851491 Modified bio-related substance, process for producing the same, and intermediate |
12/14/2010 | US7851458 Cartilage enhancing food supplements and methods of preparing the same |
12/14/2010 | US7851454 Short immunomodulatory oligonucleotides |
12/14/2010 | US7851447 Applying at least one chondroitin sulfate proteoglycan-degrading enzyme to the damaged nerve for promoting repair of a damaged nerve |
12/14/2010 | US7851437 monoclonal antibody conjugated with peptide drug such as dolastatin derivative |
12/14/2010 | US7851432 Maytansine derivatives having a sterically hindered thiol or disulfide groups, capable of conjugating to cell-binding agents, to form drugs having improved therapeutic efficacy in animal tumor models; antitumor agents |
12/14/2010 | US7850995 having a cationic surfactant adsorbed on their surfaces to provide superior adhesion to a biological substrate, e.g., an insect, teeth, bone, nails, chitin, feathers, plants, mucous, skin; drug delivery |
12/14/2010 | US7850993 Drug-releasing system of biodegradable polymer type |
12/14/2010 | US7850991 Calcium formate for use as a dietary supplement |
12/14/2010 | US7850971 PSMA antibodies and protein multimers |
12/14/2010 | US7850969 Apparatus for reducing secretory activity of leukocytes which comprises plastic housing, carriers, blood inlet/outlet nozzles and an antibody against Fas (CD95) that is linked to the carrier |
12/14/2010 | US7850962 Isolated human monoclonal antibodies which bind to lymphocyte function associated antigens; therapy and diagnosis methods; skin disorders; antiarthritic agents; inflammatory bowel disease |
12/14/2010 | CA2504755C Carbohydrate-based synthetic vaccines for hiv |
12/14/2010 | CA2485424C Cytotoxic agents comprising polyethylene glycol-containing taxanes and their therapeutic use |
12/14/2010 | CA2478811C Tasted masked veterinary solid compositions |
12/14/2010 | CA2462376C Liposome loading with metal ions |
12/14/2010 | CA2461890C Water soluble nanoparticles of hydrophilic and hydrophobic active materials |
12/14/2010 | CA2459472C Sustained release micropellets and process for producing the same |
12/14/2010 | CA2449769C S-omeprazole (esomeprazole) inclusion complex with cyclodextrins |
12/14/2010 | CA2309633C Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates |
12/14/2010 | CA2235069C Methods and compositions to improve germ cell and embryo survival and function |
12/14/2010 | CA2171942C Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs |
12/14/2010 | CA2152917C Liposome with oligosaccharide on surface |
12/09/2010 | WO2010141902A2 METHODS FOR IDENTIFICATION OF SITES FOR IgG CONJUGATION |
12/09/2010 | WO2010141806A2 Compositions and methods for delivery of materials |
12/09/2010 | WO2010141591A1 Omega-3 oil containing ophthalmic emulsions |
12/09/2010 | WO2010141566A1 Conjugation methods |
12/09/2010 | WO2010141507A1 Biomolecule-polymer conjugates and methods of making same |
12/09/2010 | WO2010140992A1 Stable pharmaceutical compositions containing rosuvastatin calcium |
12/09/2010 | WO2010140869A2 Complex, multilayer using the same, and device coated with the multilayer |
12/09/2010 | WO2010140686A1 Emulsifying preparation |
12/09/2010 | WO2010140401A1 Microneedle array using porous substrate and process for producing same |
12/09/2010 | WO2010140377A1 Vaccine for mycoplasma infection |
12/09/2010 | WO2010140154A1 Proteins modified with (amino)-monosaccharide-biotin adduct |
12/09/2010 | WO2010140148A1 Prodrugs containing albumin binding probe |
12/09/2010 | WO2010139958A1 Anti-microbial alginate oligomers |
12/09/2010 | WO2010139957A1 Alginate oligomers for use in overcoming multidrug resistance in bacteria |
12/09/2010 | WO2010139956A1 Treatment of acinetobacter with alginate oligomers and antibiotics |
12/09/2010 | WO2010139942A2 Nanoparticle for biomolecule delivery |
12/09/2010 | WO2010139752A2 Stabilised composition comprising at least one adrenergic compound |
12/09/2010 | WO2010139751A2 Stabilised composition comprising at least one adrenergic compound |
12/09/2010 | WO2010139111A1 Sustained release dosage form |
12/09/2010 | WO2010139003A1 Chelating amphiphiles |
12/09/2010 | WO2010095912A3 Method for manufacturing non-soluble drug nanocomplex |
12/09/2010 | WO2010093460A3 Particle size-structured parenteral dispersions |
12/09/2010 | WO2009150284A3 Apo-a conjugates for the administration of biologically active compounds |
12/09/2010 | WO2009142525A3 Capsulating system binding to nucleolin |
12/09/2010 | US20100312328 Drug-delivery endovascular stent and method of forming the same |
12/09/2010 | US20100311935 Moisture curable materials for delivery of agents, methods, and medical devices |
12/09/2010 | US20100311846 Methods for controlling water amount in a polymer composition or substrate |
12/09/2010 | US20100311845 Glycosidase enzymes |